Testicular Cancer Incidence in Eight Northern European Countries: Secular and Recent Trends

Author:

Richiardi Lorenzo12,Bellocco Rino1,Adami Hans-Olov1,Torrång Anna1,Barlow Lotti3,Hakulinen Timo4,Rahu Mati56,Stengrevics Aivars7,Storm Hans8,Tretli Steinar9,Kurtinaitis Juozas10,Tyczynski Jerzy E.11,Akre Olof12

Affiliation:

1. 1Department of Medical Epidemiology and Biostatistics and

2. 4Unit of Cancer Epidemiology, CeRMS and Center for Oncologic Prevention, University of Turin, Italy;

3. 3Centre for Epidemiology, National Board of Health and Welfare, Stockholm, Sweden;

4. 5Finnish Cancer Registry, Helsinki, Finland;

5. 6Department of Epidemiology and Biostatistics, Institute of Experimental and Clinical Medicine and

6. 7National Centre for Excellence in Behavioural and Health Sciences, Tallinn, Estonia;

7. 8Latvian Oncology Center, Riga, Latvia;

8. 9Cancer Prevention & Documentation, Danish Cancer Society, Copenhagen, Denmark;

9. 10Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway;

10. 11Lithuanian Cancer Registry, Vilnius University Oncology Institute, Lithuania; and

11. 12Unit of Descriptive Epidemiology, IARC, Lyon, France

12. 2Clinical Epidemiology Unit, Department of Medicine, Karolinska Hospital, Karolinska Institutet,

Abstract

Abstract Objective: Striking geographic variation and marked increasing secular trends characterize the incidence of testicular cancer. However, it is not known whether these patterns have attenuated in recent years and whether they are similar for seminomas and nonseminomas, the two main histologic groups of testicular cancer. Method: Cancer registry data, including 27,030 testicular cancer cases, were obtained from Denmark, Estonia, Finland, Latvia, Lithuania, Norway, Poland, and Sweden. Between 57 (Denmark) and 9 (Poland) years of registration were covered. Country-specific temporal trends were estimated, with focus on the last decade and seminomas and nonseminomas. Data from the Nordic countries were further analyzed using an age-period-cohort approach. Results: Age-standardized incidence rates increased annually by 2.6% to 4.9% during the study period, with marginal differences between seminomas and nonseminomas. In the last decade, the increasing trend attenuated only in Denmark (annual change, −0.3%; 95% confidence interval, −1.5 to 0.9). In 1995, the highest and the lowest age-standardized incidence rates (per 105) were 15.2 in Denmark and 2.1 in Lithuania. Incidence rates (i.e., for all cancers and for seminomas and nonseminomas, separately) depended chiefly on birth cohort rather than on calendar period of diagnosis (although both birth cohort and period determined the Danish incidence rates). Conclusions: Testicular cancer incidence is still increasing, with the exception of Denmark, and a large geographic difference exists. The increasing trend is mainly a birth cohort phenomenon also in recent cohorts. Temporal trends for seminomas and nonseminomas are similar, which suggests that they share important causal factors.

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3